Payment overview · 2025
General Payments
$50.87
2 reported records · 2 companies
Healthcare provider profile · identity verified
Michael Ryan Brackman, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · PINEHURST, NC · NPI 1194045948
Verified facts
What the public records show
CMS Open Payments records show Michael Ryan Brackman, D.O. received $50.87 in general payments during 2025 across 2 reported records.
Genentech USA, Inc. accounted for 59.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 189 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Genentech USA, Inc. | Unresolved — no canonical attribution shown | $30.45 | 59.9% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $20.42 | 40.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $50.87 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Phesgo Normalized: phesgo |
Biological | Genentech USA, Inc. | $30.45 | 1 | 2025 |
Source payment records
|
|||||
| VYNDAQEL Normalized: vyndaqel |
Drug | PFIZER INC. | $20.42 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
189 | 43 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1021 | 276 |
| Amlodipine Besylate | Amlodipine Besylate | 767 | 224 |
| Levothyroxine Sodium | Levothyroxine Sodium | 735 | 197 |
| Lisinopril | Lisinopril | 657 | 194 |
| Gabapentin | Gabapentin | 612 | 183 |
| Losartan Potassium | Losartan Potassium | 523 | 145 |
| Hydrochlorothiazide | Hydrochlorothiazide | 490 | 141 |
| Omeprazole | Omeprazole | 486 | 142 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 320 | 91 |
| Jardiance | Empagliflozin | 309 | 75 |
| Metformin Hcl | Metformin Hcl | 309 | 89 |
| Simvastatin | Simvastatin | 309 | 82 |
| Duloxetine Hcl | Duloxetine Hcl | 301 | 82 |
| Trazodone Hcl | Trazodone Hcl | 298 | 85 |
| Sertraline Hcl | Sertraline Hcl | 291 | 79 |
| Metoprolol Succinate | Metoprolol Succinate | 290 | 76 |
| Pravastatin Sodium | Pravastatin Sodium | 280 | 83 |
| Pantoprazole Sodium | Pantoprazole Sodium | 229 | 67 |
| Potassium Chloride | Potassium Chloride | 222 | 64 |
| Furosemide | Furosemide | 218 | 68 |
| Eliquis | Apixaban | 189 | 43 |
| Famotidine | Famotidine | 168 | 58 |
| Montelukast Sodium | Montelukast Sodium | 163 | 45 |
| Metoprolol Tartrate | Metoprolol Tartrate | 160 | 49 |
| Allopurinol | Allopurinol | 157 | 46 |
| Alprazolam | Alprazolam | 154 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 144 | 52 |
| Fluticasone Propionate | Fluticasone Propionate | 144 | 51 |
| Spironolactone | Spironolactone | 139 | 43 |
| Metformin Hcl Er | Metformin Hcl | 135 | 38 |
| Carvedilol | Carvedilol | 130 | 39 |
| Meloxicam | Meloxicam | 130 | 42 |
| Atenolol | Atenolol | 128 | 37 |
| Celecoxib | Celecoxib | 127 | 52 |
| Warfarin Sodium | Warfarin Sodium | 121 | 30 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 119 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 117 | 38 |
| Pioglitazone Hcl | Pioglitazone Hcl | 114 | 31 |
| Zolpidem Tartrate | Zolpidem Tartrate | 114 | 24 |
| Trulicity | Dulaglutide | 109 | 23 |
| Tramadol Hcl | Tramadol Hcl | 106 | 46 |
| Valsartan | Valsartan | 104 | 32 |
| Alendronate Sodium | Alendronate Sodium | 102 | 43 |
| Citalopram Hbr | Citalopram Hydrobromide | 102 | 30 |
| Ozempic | Semaglutide | 96 | 24 |
| Mirtazapine | Mirtazapine | 94 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 93 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 92 | 27 |
| Topiramate | Topiramate | 87 | 31 |
| Donepezil Hcl | Donepezil Hcl | 83 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 83 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 79 | 28 |
| Synthroid | Levothyroxine Sodium | 79 | 20 |
| Bupropion Xl | Bupropion Hcl | 76 | 25 |
| Ezetimibe | Ezetimibe | 76 | 24 |
| Mounjaro | Tirzepatide | 71 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 70 | 19 |
| Glimepiride | Glimepiride | 69 | 18 |
| Lorazepam | Lorazepam | 68 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 68 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 66 | 29 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 65 | 12 |
| Benazepril Hcl | Benazepril Hcl | 63 | 17 |
| Nifedipine Er | Nifedipine | 61 | 12 |
| Lovastatin | Lovastatin | 60 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 59 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 59 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 57 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 57 | 26 |
| Doxepin Hcl | Doxepin Hcl | 54 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 18 |
| Propranolol Hcl | Propranolol Hcl | 53 | 11 |
| Buspirone Hcl | Buspirone Hcl | 50 | 15 |
| Finasteride | Finasteride | 47 | 14 |
| Prednisone | Prednisone | 47 | 41 |
| Clonazepam | Clonazepam | 45 | suppressed |
| Glipizide | Glipizide | 45 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 43 | 16 |
| Enalapril Maleate | Enalapril Maleate | 42 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 42 | 14 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 42 | 13 |
| Xarelto | Rivaroxaban | 42 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 41 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 41 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 39 | 11 |
| Fenofibrate | Fenofibrate | 37 | suppressed |
| Chlorthalidone | Chlorthalidone | 36 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 36 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 34 | suppressed |
| Estradiol | Estradiol | 34 | 14 |
| Memantine Hcl | Memantine Hcl | 34 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 34 | 11 |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Pregabalin | Pregabalin | 33 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 32 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 32 | suppressed |
| Ibuprofen | Ibuprofen | 30 | 13 |
| Torsemide | Torsemide | 30 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 29 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 29 | 26 |
| Colchicine | Colchicine | 29 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 29 | 15 |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 29 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Ketoconazole | Ketoconazole | 28 | 18 |
| Ramipril | Ramipril | 28 | suppressed |
| Baclofen | Baclofen | 27 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 27 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 21 |
| Acyclovir | Acyclovir | 25 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Telmisartan | Telmisartan | 24 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Fluconazole | Fluconazole | 23 | 14 |
| Linzess | Linaclotide | 23 | suppressed |
| Risperidone | Risperidone | 23 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 22 | suppressed |
| Diazepam | Diazepam | 22 | suppressed |
| Levemir Flexpen | Insulin Detemir | 22 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 22 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 22 | suppressed |
| Temazepam | Temazepam | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Methocarbamol | Methocarbamol | 21 | suppressed |
| Myrbetriq | Mirabegron | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 20 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 20 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 15 |
| Nystatin | Nystatin | 16 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 14 | suppressed |
| Amoxicillin | Amoxicillin | 14 | 11 |
| Arnuity Ellipta | Fluticasone Furoate | 14 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 14 | suppressed |
| Easy Comfort Pen Needles | Pen Needle, Diabetic | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Indapamide | Indapamide | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Sucralfate | Sucralfate | 13 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Klor-Con | Potassium Chloride | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Kerendia | Finerenone | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 11 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $50.87 · 2 records | Genentech USA, Inc. | Phesgo, VYNDAQEL | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error